Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors

Exp Parasitol. 2009 Mar;121(3):288-91. doi: 10.1016/j.exppara.2008.11.010. Epub 2008 Dec 6.

Abstract

In the present study, we examined the effect of the histone deacetylase (HDAC) inhibitors trichostatin A (TSA), valproic acid (VA) and sodium-butyrate on the metamorphosis of larvae of the human blood-fluke Schistosoma mansoni from the free-swimming miracidia into the intramolluskal sporocyst. We show that HDAC inhibitors block transformation in concentration dependant manner. TSA reversibly blocks this developmental process: only 13+/-11% of TSA treated miracidia transform into sporocysts in-vitro, compared to 92+/-3% in the mock-treated control. Other enzyme inhibitors such as cycloheximide or hydroxyurea had no effect on metamorphosis. For treatment of up to 4 h, the effect of TSA was completely reversible. Our data indicates that HDAC activity is necessary for the transformation of S. mansoni miracidia during infection of the snail host.

MeSH terms

  • Animals
  • Biomphalaria / parasitology
  • Butyrates / pharmacology
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology*
  • Histone Deacetylase Inhibitors*
  • Hydroxamic Acids / pharmacology
  • Larva / drug effects
  • Larva / growth & development
  • Mesocricetus
  • Metamorphosis, Biological / drug effects*
  • Schistosoma mansoni / drug effects*
  • Schistosoma mansoni / growth & development
  • Valproic Acid / pharmacology

Substances

  • Butyrates
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • trichostatin A
  • Valproic Acid